symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
NWBO,0.65915,-0.142015,2506557,766466208,0,0.4-1.27,0.0071,"Northwest Biotherapeutics, Inc.",USD,0001072379,US66737P6007,66737P600,Other OTC,PNK,Biotechnology,https://www.nwbio.com,"Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, which is in Phase I/II clinical trials to treat inoperable solid tumors. The company was founded in 1996 and is headquartered in Bethesda, Maryland.",Ms. Linda F. Powers J.D.,Healthcare,US,22,240 497 9024,4800 Montgomery Lane,Bethesda,MD,20814,0.0150506,1.16505,https://financialmodelingprep.com/image-stock/NWBO.png,2001-12-14,False,False,True,False,False
